Norges Bank Form 8.3 - AbbVie Inc
07 5월 2020 - 6:45PM
UK Regulatory
TIDM0QCV
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
1. KEY INFORMATION
Name of person dealing (Note Norges Bank
1)
Company dealt in AbbVie Inc
Class of relevant security US$0.01 common stock
to which the dealings being US00287Y1091
disclosed relate (Note 2)
Date of dealing 06/05/2020
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of
relevant security dealt in (Note 3)
Long Short
Number (%) Number (%)
(1) Relevant securities 13,836,342 (0.91%)
(2) Derivatives (other than 1,234,300 (0.11%)
options)
(3) Options and agreements to
purchase/sell
Total 15,070,642 (1.02%)
(b) Interests and short positions in relevant securities of the company,
other than the class dealt in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than
options)
(3) Options and agreements to
purchase/sell
Total
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant Price per unit
securities (Note 5)
Purchase 440,100 85.4200 USD
(b) Derivatives transactions (other than options transactions)
Product Nature of Number of relevant Price per
name, transaction securities unit
e.g. CFD (Note 6) (Note 7) (Note 5)
CFD Sale 440,100 85.4200 USD
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product Writing, Number of Exercise Type, Expiry Option
name, selling, securities price e.g. date money
e.g. call purchasing, to which American, paid/
option varying the option European received
etc. relates etc. per unit
(Note 7) (Note 5)
(ii) Exercising
Product name, Number of securities Exercise price
e.g. call per unit (Note
option 5)
(d) Other dealings (including transactions in respect of new
securities) (Note 4)
Nature of Details Price per unit
transaction (if applicable)
(Note 8) (Note 5)
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which
any derivative referred to on this form is referenced. If none, this should be
stated.
Is a Supplemental Form 8 attached? (Note 9)
[DEL:YES:DEL]/NO
Date of disclosure 07/05/2020
Contact name Philippe Chiaroni
Telephone number +47 2407 3297
If a connected EFM, name of
offeree/offeror with which
connected
If a connected EFM, state
nature of connection (Note
10)
END
(END) Dow Jones Newswires
May 07, 2020 05:45 ET (09:45 GMT)
Abbvie (LSE:0QCV)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
Abbvie (LSE:0QCV)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024